Comparison of insulin detemir and insulin glargine in a basal—bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: A 52-week, multinational, randomized, open-label, parallel-group, Treat-to-Target noninferiority trial

Simon Heller, Christoph Koenen, Bruce W. Bode

Clinical Therapeutics · 2009 · 94 citations · 17 references

Concepts

References

17